These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 31365658)
21. Item-specific patterns of the Skindex-17 in individuals with different levels of Hidradenitis Suppurativa severity: a network analysis study. Raimondi G; Samela T; Fania L; Abeni D Front Public Health; 2023; 11():1284365. PubMed ID: 38026379 [TBL] [Abstract][Full Text] [Related]
22. Hidradenitis suppurativa and associated diseases. Pescitelli L; Ricceri F; Prignano F G Ital Dermatol Venereol; 2018 Jun; 153(3 Suppl 2):8-17. PubMed ID: 30468375 [TBL] [Abstract][Full Text] [Related]
23. Assessing the psychological burden of patients with hidradenitis suppurativa. Frings VG; Bauer B; Glöditzsch M; Goebeler M; Presser D Eur J Dermatol; 2019 Jun; 29(3):294-301. PubMed ID: 31145081 [TBL] [Abstract][Full Text] [Related]
24. Self-Reported Pain Alleviating Methods in Patients with Hidradenitis Suppurativa. Ravn Jørgensen AH; Yao Y; Thomsen SF; Christian Ring H Actas Dermosifiliogr (Engl Ed); 2021 Feb; 112(2):153-158. PubMed ID: 33232705 [TBL] [Abstract][Full Text] [Related]
26. Comparative Study of Quality of Life and Psychological Aspects in Patients with Psoriasis and Hidradenitis Suppurativa. Kouris A; Platsidaki E; Efstathiou V; Katoulis A; Markantoni V; Tsatovidou R; Christodoulou C; Rigopoulos D; Kontochristopoulos G Acta Dermatovenerol Croat; 2021 Nov; 29(4):203-210. PubMed ID: 36896691 [TBL] [Abstract][Full Text] [Related]
27. Cutaneous body image in patients with hidradenitis suppurativa: a hospital-based cross-sectional study. Koumaki D; Rovithi E; Solia Apokidou E; Papadakis M; Katoulis A; Evangelou G Sci Rep; 2023 May; 13(1):7898. PubMed ID: 37193758 [TBL] [Abstract][Full Text] [Related]
28. Hidradenitis suppurativa and psychosocial well-being: a cross-sectional survey analysis from the All of Us research program. Jain S; Tushe S; Sood A; Yeung H; Orenstein LAV Arch Dermatol Res; 2024 Jul; 316(7):445. PubMed ID: 38955839 [TBL] [Abstract][Full Text] [Related]
29. Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa. Braunberger TL; Nartker NT; Nicholson CL; Nahhas AF; Parks-Miller A; Hanna Z; Jayaprakash R; Ramesh MS; Rambhatla PV; Hamzavi IH Int J Dermatol; 2018 Sep; 57(9):1088-1093. PubMed ID: 29774531 [TBL] [Abstract][Full Text] [Related]
30. Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study. Janse IC; Deckers IE; van der Maten AD; Evers AWM; Boer J; van der Zee HH; Prens EP; Horváth B Br J Dermatol; 2017 Apr; 176(4):1042-1047. PubMed ID: 27534591 [TBL] [Abstract][Full Text] [Related]
31. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa? Pavon Blanco A; Turner MA; Petrof G; Weinman J Br J Dermatol; 2019 Feb; 180(2):338-345. PubMed ID: 30171696 [TBL] [Abstract][Full Text] [Related]
32. Hidradenitis suppurativa through the lens of YouTube: A cross-sectional analysis. Li W; Ma JE; Chan AA; Lee DJ; Smogorzewski J J Am Acad Dermatol; 2021 May; 84(5):1398-1399. PubMed ID: 32522514 [No Abstract] [Full Text] [Related]
33. Convergent Validity of Suffering and Quality of Life as Measured by The Hidradenitis Suppurativa Quality of Life. Kursawe Larsen C; Kjaersgaard Andersen R; Kirby JS; Tan J; Saunte DML; Jemec GBE J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):1577-1581. PubMed ID: 33539563 [TBL] [Abstract][Full Text] [Related]
34. Factors affecting quality of life in patients with hidradenitis suppurativa. Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682 [TBL] [Abstract][Full Text] [Related]
35. Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, Concomitant Conditions, and Diagnostic Delay in a University Teaching Hospital in Buenos Aires, Argentina. Zimman S; Comparatore MV; Vulcano AF; Absi ML; Mazzuoccolo LD Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):297-302. PubMed ID: 30885385 [TBL] [Abstract][Full Text] [Related]
36. Quality of life in patients with early- and late-onset hidradenitis suppurativa. Sampogna F; Fania L; Mastroeni S; Fusari R; Panebianco A; Abeni D Arch Dermatol Res; 2023 Apr; 315(3):473-479. PubMed ID: 35997825 [TBL] [Abstract][Full Text] [Related]
37. Quality of Life in Hidradenitis Suppurativa: validation of the HSQoL-24. Marron SE; Gomez-Barrera M; Tomas Aragones L; Goni-Navarro A; Vilarrasa-Rull E; Diaz-Diaz RM; Garcia-Latasa de Aranibar FJ; Campos-Rodenas R; Fuentelsaz Del Barrio V; Gilaberte-Calzada Y; Gracia-Cazaña T; Morales-Callaghan AM; Ros-Abarca S; Madrid-Alvarez MB; Puig L Acta Derm Venereol; 2021 Aug; 101(8):adv00529. PubMed ID: 34427316 [TBL] [Abstract][Full Text] [Related]
38. Morbidity in patients with hidradenitis suppurativa. von der Werth JM; Jemec GB Br J Dermatol; 2001 Apr; 144(4):809-13. PubMed ID: 11298541 [TBL] [Abstract][Full Text] [Related]
39. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. Wolkenstein P; Loundou A; Barrau K; Auquier P; Revuz J; J Am Acad Dermatol; 2007 Apr; 56(4):621-3. PubMed ID: 17097366 [TBL] [Abstract][Full Text] [Related]